nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—CYP2C8—Spironolactone—dilated cardiomyopathy	0.298	0.409	CbGbCtD
Levomilnacipran—ABCB1—Lisinopril—dilated cardiomyopathy	0.229	0.314	CbGbCtD
Levomilnacipran—ABCB1—Spironolactone—dilated cardiomyopathy	0.202	0.277	CbGbCtD
Levomilnacipran—Blood cholesterol increased—Furosemide—dilated cardiomyopathy	0.0108	0.0396	CcSEcCtD
Levomilnacipran—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00627	0.0231	CcSEcCtD
Levomilnacipran—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00461	0.0169	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00442	0.0163	CcSEcCtD
Levomilnacipran—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00393	0.0144	CcSEcCtD
Levomilnacipran—Bladder pain—Furosemide—dilated cardiomyopathy	0.00392	0.0144	CcSEcCtD
Levomilnacipran—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00378	0.0139	CcSEcCtD
Levomilnacipran—Proteinuria—Lisinopril—dilated cardiomyopathy	0.0037	0.0136	CcSEcCtD
Levomilnacipran—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00368	0.0135	CcSEcCtD
Levomilnacipran—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00365	0.0134	CcSEcCtD
Levomilnacipran—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.0036	0.0133	CcSEcCtD
Levomilnacipran—Thirst—Furosemide—dilated cardiomyopathy	0.00331	0.0122	CcSEcCtD
Levomilnacipran—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00318	0.0117	CcSEcCtD
Levomilnacipran—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00316	0.0116	CcSEcCtD
Levomilnacipran—Cystitis—Lisinopril—dilated cardiomyopathy	0.00314	0.0116	CcSEcCtD
Levomilnacipran—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00312	0.0115	CcSEcCtD
Levomilnacipran—Irritability—Furosemide—dilated cardiomyopathy	0.003	0.0111	CcSEcCtD
Levomilnacipran—Urinary retention—Furosemide—dilated cardiomyopathy	0.00299	0.011	CcSEcCtD
Levomilnacipran—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00294	0.0108	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00278	0.0102	CcSEcCtD
Levomilnacipran—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00274	0.0101	CcSEcCtD
Levomilnacipran—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00256	0.00941	CcSEcCtD
Levomilnacipran—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00255	0.00937	CcSEcCtD
Levomilnacipran—Somnolence—Spironolactone—dilated cardiomyopathy	0.00253	0.0093	CcSEcCtD
Levomilnacipran—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00251	0.00925	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00246	0.00904	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00241	0.00885	CcSEcCtD
Levomilnacipran—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00237	0.00873	CcSEcCtD
Levomilnacipran—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00234	0.00862	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00229	0.00844	CcSEcCtD
Levomilnacipran—Urticaria—Spironolactone—dilated cardiomyopathy	0.00226	0.00831	CcSEcCtD
Levomilnacipran—Irritability—Lisinopril—dilated cardiomyopathy	0.00225	0.0083	CcSEcCtD
Levomilnacipran—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00225	0.00827	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00215	0.00791	CcSEcCtD
Levomilnacipran—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00213	0.00786	CcSEcCtD
Levomilnacipran—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00213	0.00785	CcSEcCtD
Levomilnacipran—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0021	0.00771	CcSEcCtD
Levomilnacipran—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00206	0.00758	CcSEcCtD
Levomilnacipran—Eye disorder—Furosemide—dilated cardiomyopathy	0.00204	0.00749	CcSEcCtD
Levomilnacipran—Pruritus—Spironolactone—dilated cardiomyopathy	0.00201	0.0074	CcSEcCtD
Levomilnacipran—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00199	0.00732	CcSEcCtD
Levomilnacipran—Angiopathy—Furosemide—dilated cardiomyopathy	0.00198	0.00727	CcSEcCtD
Levomilnacipran—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00195	0.00716	CcSEcCtD
Levomilnacipran—Dysuria—Lisinopril—dilated cardiomyopathy	0.00191	0.00702	CcSEcCtD
Levomilnacipran—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00191	0.00702	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.0019	0.00698	CcSEcCtD
Levomilnacipran—Malnutrition—Furosemide—dilated cardiomyopathy	0.0019	0.00698	CcSEcCtD
Levomilnacipran—Dizziness—Spironolactone—dilated cardiomyopathy	0.00188	0.00692	CcSEcCtD
Levomilnacipran—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00188	0.00692	CcSEcCtD
Levomilnacipran—Flatulence—Furosemide—dilated cardiomyopathy	0.00187	0.00687	CcSEcCtD
Levomilnacipran—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00186	0.00683	CcSEcCtD
Levomilnacipran—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00185	0.0068	CcSEcCtD
Levomilnacipran—Vomiting—Spironolactone—dilated cardiomyopathy	0.00181	0.00665	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.0018	0.00664	CcSEcCtD
Levomilnacipran—Rash—Spironolactone—dilated cardiomyopathy	0.00179	0.0066	CcSEcCtD
Levomilnacipran—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00179	0.00659	CcSEcCtD
Levomilnacipran—Vision blurred—Furosemide—dilated cardiomyopathy	0.00179	0.00657	CcSEcCtD
Levomilnacipran—Headache—Spironolactone—dilated cardiomyopathy	0.00178	0.00656	CcSEcCtD
Levomilnacipran—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00177	0.00651	CcSEcCtD
Levomilnacipran—Agitation—Furosemide—dilated cardiomyopathy	0.00174	0.00641	CcSEcCtD
Levomilnacipran—Haematuria—Lisinopril—dilated cardiomyopathy	0.00174	0.00639	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00172	0.00633	CcSEcCtD
Levomilnacipran—Leukopenia—Furosemide—dilated cardiomyopathy	0.0017	0.00624	CcSEcCtD
Levomilnacipran—Nausea—Spironolactone—dilated cardiomyopathy	0.00169	0.00622	CcSEcCtD
Levomilnacipran—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00163	0.00601	CcSEcCtD
Levomilnacipran—Hallucination—Lisinopril—dilated cardiomyopathy	0.00163	0.00598	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00161	0.00594	CcSEcCtD
Levomilnacipran—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00161	0.00592	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0016	0.0059	CcSEcCtD
Levomilnacipran—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.0016	0.00589	CcSEcCtD
Levomilnacipran—Dry mouth—Furosemide—dilated cardiomyopathy	0.00158	0.00581	CcSEcCtD
Levomilnacipran—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00154	0.00569	CcSEcCtD
Levomilnacipran—Shock—Furosemide—dilated cardiomyopathy	0.00152	0.0056	CcSEcCtD
Levomilnacipran—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00152	0.00558	CcSEcCtD
Levomilnacipran—Flushing—Lisinopril—dilated cardiomyopathy	0.00152	0.00558	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00151	0.00557	CcSEcCtD
Levomilnacipran—Skin disorder—Furosemide—dilated cardiomyopathy	0.0015	0.00553	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.0015	0.0055	CcSEcCtD
Levomilnacipran—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00148	0.00546	CcSEcCtD
Levomilnacipran—Anorexia—Furosemide—dilated cardiomyopathy	0.00147	0.00543	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00147	0.00542	CcSEcCtD
Levomilnacipran—Chills—Lisinopril—dilated cardiomyopathy	0.00147	0.0054	CcSEcCtD
Levomilnacipran—Hypotension—Furosemide—dilated cardiomyopathy	0.00145	0.00532	CcSEcCtD
Levomilnacipran—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00143	0.00527	CcSEcCtD
Levomilnacipran—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00142	0.00523	CcSEcCtD
Levomilnacipran—Flatulence—Lisinopril—dilated cardiomyopathy	0.0014	0.00516	CcSEcCtD
Levomilnacipran—Tension—Lisinopril—dilated cardiomyopathy	0.0014	0.00514	CcSEcCtD
Levomilnacipran—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00139	0.00513	CcSEcCtD
Levomilnacipran—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00139	0.00511	CcSEcCtD
Levomilnacipran—Somnolence—Furosemide—dilated cardiomyopathy	0.00138	0.00506	CcSEcCtD
Levomilnacipran—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00135	0.00495	CcSEcCtD
Levomilnacipran—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00134	0.00493	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00134	0.00492	CcSEcCtD
Levomilnacipran—Fatigue—Furosemide—dilated cardiomyopathy	0.00133	0.00491	CcSEcCtD
Levomilnacipran—Tremor—Lisinopril—dilated cardiomyopathy	0.00133	0.0049	CcSEcCtD
Levomilnacipran—Constipation—Furosemide—dilated cardiomyopathy	0.00132	0.00487	CcSEcCtD
Levomilnacipran—Syncope—Lisinopril—dilated cardiomyopathy	0.00128	0.00469	CcSEcCtD
Levomilnacipran—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00127	0.00469	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00127	0.00466	CcSEcCtD
Levomilnacipran—Palpitations—Lisinopril—dilated cardiomyopathy	0.00126	0.00463	CcSEcCtD
Levomilnacipran—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00125	0.0046	CcSEcCtD
Levomilnacipran—Urticaria—Furosemide—dilated cardiomyopathy	0.00123	0.00452	CcSEcCtD
Levomilnacipran—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00122	0.0045	CcSEcCtD
Levomilnacipran—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00122	0.0045	CcSEcCtD
Levomilnacipran—Chest pain—Lisinopril—dilated cardiomyopathy	0.00121	0.00446	CcSEcCtD
Levomilnacipran—Anxiety—Lisinopril—dilated cardiomyopathy	0.00121	0.00444	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.0012	0.00443	CcSEcCtD
Levomilnacipran—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00118	0.00436	CcSEcCtD
Levomilnacipran—Infection—Lisinopril—dilated cardiomyopathy	0.00115	0.00424	CcSEcCtD
Levomilnacipran—Shock—Lisinopril—dilated cardiomyopathy	0.00114	0.0042	CcSEcCtD
Levomilnacipran—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00114	0.00419	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00114	0.00418	CcSEcCtD
Levomilnacipran—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00113	0.00417	CcSEcCtD
Levomilnacipran—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00113	0.00415	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00112	0.00413	CcSEcCtD
Levomilnacipran—Asthenia—Furosemide—dilated cardiomyopathy	0.00111	0.00409	CcSEcCtD
Levomilnacipran—Anorexia—Lisinopril—dilated cardiomyopathy	0.00111	0.00407	CcSEcCtD
Levomilnacipran—Pruritus—Furosemide—dilated cardiomyopathy	0.00109	0.00403	CcSEcCtD
Levomilnacipran—Hypotension—Lisinopril—dilated cardiomyopathy	0.00108	0.00399	CcSEcCtD
Levomilnacipran—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00106	0.0039	CcSEcCtD
Levomilnacipran—Insomnia—Lisinopril—dilated cardiomyopathy	0.00105	0.00386	CcSEcCtD
Levomilnacipran—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00104	0.00384	CcSEcCtD
Levomilnacipran—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00103	0.00381	CcSEcCtD
Levomilnacipran—Somnolence—Lisinopril—dilated cardiomyopathy	0.00103	0.0038	CcSEcCtD
Levomilnacipran—Dizziness—Furosemide—dilated cardiomyopathy	0.00102	0.00377	CcSEcCtD
Levomilnacipran—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00102	0.00376	CcSEcCtD
Levomilnacipran—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00101	0.00371	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.001	0.00369	CcSEcCtD
Levomilnacipran—Fatigue—Lisinopril—dilated cardiomyopathy	0.001	0.00368	CcSEcCtD
Levomilnacipran—Constipation—Lisinopril—dilated cardiomyopathy	0.000993	0.00365	CcSEcCtD
Levomilnacipran—Vomiting—Furosemide—dilated cardiomyopathy	0.000984	0.00362	CcSEcCtD
Levomilnacipran—Rash—Furosemide—dilated cardiomyopathy	0.000976	0.00359	CcSEcCtD
Levomilnacipran—Dermatitis—Furosemide—dilated cardiomyopathy	0.000975	0.00359	CcSEcCtD
Levomilnacipran—Headache—Furosemide—dilated cardiomyopathy	0.000969	0.00357	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000949	0.00349	CcSEcCtD
Levomilnacipran—Urticaria—Lisinopril—dilated cardiomyopathy	0.000922	0.00339	CcSEcCtD
Levomilnacipran—Nausea—Furosemide—dilated cardiomyopathy	0.000919	0.00338	CcSEcCtD
Levomilnacipran—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000918	0.00338	CcSEcCtD
Levomilnacipran—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000918	0.00338	CcSEcCtD
Levomilnacipran—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000855	0.00315	CcSEcCtD
Levomilnacipran—Asthenia—Lisinopril—dilated cardiomyopathy	0.000833	0.00307	CcSEcCtD
Levomilnacipran—Pruritus—Lisinopril—dilated cardiomyopathy	0.000821	0.00302	CcSEcCtD
Levomilnacipran—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000794	0.00292	CcSEcCtD
Levomilnacipran—Dizziness—Lisinopril—dilated cardiomyopathy	0.000768	0.00283	CcSEcCtD
Levomilnacipran—Vomiting—Lisinopril—dilated cardiomyopathy	0.000738	0.00272	CcSEcCtD
Levomilnacipran—Rash—Lisinopril—dilated cardiomyopathy	0.000732	0.00269	CcSEcCtD
Levomilnacipran—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000731	0.00269	CcSEcCtD
Levomilnacipran—Headache—Lisinopril—dilated cardiomyopathy	0.000727	0.00268	CcSEcCtD
Levomilnacipran—Nausea—Lisinopril—dilated cardiomyopathy	0.00069	0.00254	CcSEcCtD
